We also showed that SLE patients with CRP levels ≥ 3 mg/L had a high chance of being at high cardiometabolic risk, assessed by the LAP, Castelli, triglycerides/HDL-C, and Kannel indexes. This evidence concerns the gene CRP and systemic lupus erythematosus.